📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. (2023)

First Author: Halford S

Attributed to: MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-22-2263

PubMed Identifier: 36652553

Publication URI: http://europepmc.org/abstract/MED/36652553

Type: Journal Article/Review

Volume: 29

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 8

ISSN: 1078-0432